Studies have shown that copper chaperone ATOX1 is involved in the ATP7A-LOX pathway associated with tumor metastasis, and the inhibition of ATOX1 expression reduces LOX activity and the rate of cancer cell metastasis [59]. Here, LOX is linked to neoplasm.